Story
Novo Nordisk Shares Decline on Eli Lilly Lawsuit, Cautious Analyst Stance

Shares of Novo Nordisk (NOVOb) fell on Tuesday as a new lawsuit against a key competitor and a reserved analyst outlook weighed on investor sentiment, highlighting the intense rivalry in the GLP-1 drug market.
Intensifying GLP-1 Rivalry
Novo Nordisk's stock declined by 1.9% to kr321.7 during the session after the company filed a lawsuit in U.S. federal court against rival drugmaker Eli Lilly. The suit alleges that Lilly's advertising for its Zepbound and Mounjaro treatments is misleading.
Specifically, Novo Nordisk claims Lilly's marketing materials compare the highest approved doses of its drugs against lower-dose formulations of Novo's Wegovy and Ozempic, while omitting Novo's own higher-dose options. Markets appeared to interpret the legal challenge not as a sign of offensive strength, but as a reflection of the mounting competitive pressure Novo Nordisk faces.
Cautious Analyst Outlook
AdThe stock's weakness was compounded by a restrained view from Wall Street. Analysts at Citi maintained a Neutral rating on Novo Nordisk, though they raised their price target to kr330 from kr290. This revised target implies limited near-term upside from current trading levels.
This sentiment aligns with a broader consensus, as the majority of 24 analysts covering the pharmaceutical giant recommend a "hold" position, according to Investing.com. The cautious stance comes as investors look ahead to the company's next quarterly results, scheduled for August 5.
Market Context
The decline in Novo Nordisk's shares was company-specific, occurring while the broader U.S. equity markets, including the S&P 500 and Nasdaq, advanced. The combination of the lawsuit, the analyst commentary, and pre-earnings caution appeared to be the primary drivers for the stock's retreat from its session open of kr324.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.